Allied Market Research published a report, titled, Human Chorionic Gonadotropin (hCG) Market by Technology (Natural Source Extraction and Recombinant Technology), Therapeutic Area (Female Infertility Treatment, Male Hypogonadism, Oligospermic Treatment, and Others), and End User (Fertility Clinics, Research Institutes, and Others): Global Opportunity Analysis and Industry Forecast, 2017-2025. The report offers detailed insights on the top investment pockets, market size & share, driving forces & opportunities, strategic developments, and competitive landscape. According to the report, the global human chorionic gonadotropin (hCG) market garnered $688 million in 2017 and is expected to reach $1,239 million by 2025, growing at a CAGR of 7.6% from 2018 to 2025.
𝗚𝗲𝘁 𝗣𝗗𝗙 𝗕𝗿𝗼𝗰𝗵𝘂𝗿𝗲 𝗢𝗳 𝗧𝗵𝗶𝘀 𝗥𝗲𝗽𝗼𝗿𝘁 𝗪𝗶𝘁𝗵 𝗗𝗲𝘁𝗮𝗶𝗹𝗲𝗱 𝗔𝗻𝗮𝗹𝘆𝘀𝗶𝘀 👉 https://www.alliedmarketresearch.com/request-sample/3418
Surge in adoption of hCG in pain management & weight loss and increase in incidence of infertility-related issues drive the growth of the market. However, warnings and cautions issued by the USFDA regarding the side-effects of hCG therapy would restrain the market growth. Conversely, the implementation of recombinant technology would create new pathways for the market players in future.
𝗖𝗼𝗺𝗽𝗿𝗲𝗵𝗲𝗻𝘀𝗶𝘃𝗲 𝗰𝗼𝗺𝗽𝗲𝘁𝗶𝘁𝗶𝘃𝗲 𝗮𝗻𝗮𝗹𝘆𝘀𝗶𝘀 𝗮𝗻𝗱 𝗽𝗿𝗼𝗳𝗶𝗹𝗲𝘀 𝗼𝗳 𝗺𝗮𝗷𝗼𝗿 𝗺𝗮𝗿𝗸𝗲𝘁 𝗽𝗹𝗮𝘆𝗲𝗿𝘀, 𝘀𝘂𝗰𝗵 𝗮𝘀
Bristol Myers Squibb Company, Merck & Co., Inc., Ferring B.V., Fresenius Kabi AG, Cigna, Sun Pharmaceutical Industries Ltd, Lee BioSolutions Inc., Sanzyme, Scripps Laboratories, and Lupin AB.
The other players operating in the global human chorionic gonadotropin (hCG) market include Kamiya Biomedical Company, Intas Pharmaceuticals, Prospec-Tany Technogene Ltd., Cipla Limited, Biocare Medical, LLC, MyBioSource, Zydus Cadila, and Life Medicare & Biotech Pvt. Ltd.
😷 𝐂𝐨𝐯𝐢𝐝-𝟏𝟗 𝐒𝐜𝐞𝐧𝐚𝐫𝐢𝐨:
- The Covid-19 pandemic and followed by lockdown has affected several manufacturing industries.
- The prolonged lockdown resulted in a disrupted supply chain and increased the prices of raw materials.
- However, as the world has been recovering from the pandemic, the market is estimated to get back on track.
Female infertility treatment segment to remain dominant by 2025
The female infertility treatment segment accounted for nearly half of the total market share in 2017. This segment is expected to maintain its dominance by 2025, owing to increase in infertility-related issues such as polycystic ovary syndrome (PCOS).
Get Detailed COVID-19 Impact Analysis on the Human Chorionic Gonadotropin (hCG) Market @ https://www.alliedmarketresearch.com/request-for-customization/3418?reqfor=covid
𝗞𝗲𝘆 𝗕𝗲𝗻𝗲𝗳𝗶𝘁𝘀 𝗳𝗼𝗿 𝗦𝘁𝗮𝗸𝗲𝗵𝗼𝗹𝗱𝗲𝗿𝘀
✦The study provides an in-depth analysis of the Human Chorionic Gonadotropin (hCG) Market along with the current trends and future estimations to elucidate the imminent investment pockets.
✦It offers Human Chorionic Gonadotropin (hCG) Market analysis from 2018 to 2025, which is expected to enable the stakeholders to capitalize on the prevailing opportunities in the market.
✦A comprehensive analysis of four regions is provided to determine the prevailing opportunities.
✦The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global Human Chorionic Gonadotropin (hCG) Market growth.
𝗔𝘃𝗲𝗻𝘂𝗲 𝗕𝗮𝘀𝗶𝗰 𝗣𝗹𝗮𝗻 | 𝗟𝗶𝗯𝗿𝗮𝗿𝘆 𝗔𝗰𝗰𝗲𝘀𝘀 | 𝟭 𝗬𝗲𝗮𝗿 𝗦𝘂𝗯𝘀𝗰𝗿𝗶𝗽𝘁𝗶𝗼𝗻 |
Sign up for Avenue subscription to access more than 12,000+ company profiles and 2,000+ niche industry market research reports at $699 per month, per seat. For a year, the client needs to purchase minimum 2 seat plan.
Request for 14 days free trial: https://www.alliedmarketresearch.com/avenue/trial/starter
“We have also published few syndicated market studies in the similar area that might be of your interest. Below are the report title for your reference, considering Impact of Covid-19 Over This Market which will help you to assess aftereffects of pandemic on short-term and long-term growth trends of this market.”
𝗔𝗯𝗼𝘂𝘁 𝗨𝘀
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.